Uveal melanomas driven by mutant GNAQ/GNA11 (Gαq proteins) activate FAK through TRIO-RHOA non-canonical Gαq; FAK, in turn, activates YAP, which promotes aberrant uveal melanoma growth [124]. Here, PTK2 is linked to uveal melanoma.